Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiaki Shirai

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Thrombosis and Thrombolysis|October 24, 2019
Pharmacodynamic assessment of prasugrel and clopidogrel in patients with non-cardioembolic stroke: a multicenter, randomized, active-control clinical trialTakenori Yamaguchi, Toshiaki Shirai, Satoshi Yoshiba, et al.
Seminars in Thrombosis and Hemostasis|October 10, 2017
Platelet CLEC-2: Roles Beyond HemostasisKatsue Suzuki-Inoue, Nagaharu Tsukiji, Toshiaki Shirai, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 3, 2023
Comparison of Prasugrel and Clopidogrel in Thrombotic Stroke Patients with Risk Factors for Ischemic Stroke Recurrence: An Integrated Analysis of PRASTRO-I, PRASTRO-II, and PRASTRO-IIITakanari Kitazono, Masahiro Kamouchi, Yuji Matsumaru, et al.
Platelets|November 27, 2023
C-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in miceRyohei Yokomori, Toshiaki Shirai, Nagaharu Tsukiji, et al.
Journal of Thrombosis and Haemostasis : JTH|July 20, 2023
Cancer-associated fibroblasts promote venous thrombosis through podoplanin/CLEC-2 interaction in podoplanin-negative lung cancer mouse modelToshiaki Shirai, Nagaharu Tsukiji, Tomoyuki Sasaki, et al.
Blood|January 23, 2016
Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2Shogo Tamura, Katsue Suzuki-Inoue, Nagaharu Tsukiji, et al.
Japanese Journal of Infectious Diseases|August 2, 2021
Detection of SARS-CoV-2 RNA Using RT-qPCR in Saliva Samples and Nasopharyngeal, Lingual, and Buccal Mucosal SwabsTomoyuki Sasaki, Osamu Inoue, Shinji Ogihara, et al.
Journal of Thrombosis and Haemostasis : JTH|March 28, 2021
CLEC-2 stimulates IGF-1 secretion from podoplanin-positive stromal cells and positively regulates erythropoiesis in miceShimon Otake, Tomoyuki Sasaki, Toshiaki Shirai, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2024
C-type lectin-like receptor-2 in platelets mediates ferric chloride-induced platelet activation and attenuates ferroptosis of endothelial cellsNagaharu Tsukiji, Ryohei Yokomori, Kazuho Takusagawa, et al.
Platelets|October 30, 2024
Development of an automated chemiluminescence enzyme immunoassay for the measurement of soluble C-type lectin-like receptor 2 (sCLEC-2) and molecular forms of sCLEC-2 measured in patient plasmaMasahide Kawamura, Makyo Ueda, Shuhei Matsushita, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Thrombosis and Thrombolysis|October 24, 2019
Pharmacodynamic assessment of prasugrel and clopidogrel in patients with non-cardioembolic stroke: a multicenter, randomized, active-control clinical trialTakenori Yamaguchi, Toshiaki Shirai, Satoshi Yoshiba, et al.
Seminars in Thrombosis and Hemostasis|October 10, 2017
Platelet CLEC-2: Roles Beyond HemostasisKatsue Suzuki-Inoue, Nagaharu Tsukiji, Toshiaki Shirai, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 3, 2023
Comparison of Prasugrel and Clopidogrel in Thrombotic Stroke Patients with Risk Factors for Ischemic Stroke Recurrence: An Integrated Analysis of PRASTRO-I, PRASTRO-II, and PRASTRO-IIITakanari Kitazono, Masahiro Kamouchi, Yuji Matsumaru, et al.
Platelets|November 27, 2023
C-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in miceRyohei Yokomori, Toshiaki Shirai, Nagaharu Tsukiji, et al.
Journal of Thrombosis and Haemostasis : JTH|July 20, 2023
Cancer-associated fibroblasts promote venous thrombosis through podoplanin/CLEC-2 interaction in podoplanin-negative lung cancer mouse modelToshiaki Shirai, Nagaharu Tsukiji, Tomoyuki Sasaki, et al.
Blood|January 23, 2016
Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2Shogo Tamura, Katsue Suzuki-Inoue, Nagaharu Tsukiji, et al.
Japanese Journal of Infectious Diseases|August 2, 2021
Detection of SARS-CoV-2 RNA Using RT-qPCR in Saliva Samples and Nasopharyngeal, Lingual, and Buccal Mucosal SwabsTomoyuki Sasaki, Osamu Inoue, Shinji Ogihara, et al.
Journal of Thrombosis and Haemostasis : JTH|March 28, 2021
CLEC-2 stimulates IGF-1 secretion from podoplanin-positive stromal cells and positively regulates erythropoiesis in miceShimon Otake, Tomoyuki Sasaki, Toshiaki Shirai, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2024
C-type lectin-like receptor-2 in platelets mediates ferric chloride-induced platelet activation and attenuates ferroptosis of endothelial cellsNagaharu Tsukiji, Ryohei Yokomori, Kazuho Takusagawa, et al.
Platelets|October 30, 2024
Development of an automated chemiluminescence enzyme immunoassay for the measurement of soluble C-type lectin-like receptor 2 (sCLEC-2) and molecular forms of sCLEC-2 measured in patient plasmaMasahide Kawamura, Makyo Ueda, Shuhei Matsushita, et al.
Pageof 4